Selective Noradrenergic Activation of BDNF Translation by Mirtazapine.

Autor: Ciraci V; Department of Life Sciences, University of Trieste, Via Licio Giorgieri, 5 (Q Building), 34127, Trieste, Italy. viviana.ciraci@units.it., Santoni L; Department of Life Sciences, University of Trieste, Via Licio Giorgieri, 5 (Q Building), 34127, Trieste, Italy., Tongiorgi E; Department of Life Sciences, University of Trieste, Via Licio Giorgieri, 5 (Q Building), 34127, Trieste, Italy.

Publikováno v: Molecular neurobiology [Mol Neurobiol] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.

Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study.

Autor: Nesti L; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Cardiopulmonary Lab, University of Pisa, Pisa, Italy., Chiriacò M; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Interdisciplinary Research Center 'Health Science', Sant'Anna School of Advanced Studies, Pisa, Italy., Sacchetta L; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Moriconi D; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Santoni L; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Cardiopulmonary Lab, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Pugliese NR; Cardiopulmonary Lab, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Gallo S; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Cimbalo N; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Forotti G; Unit of Internal Medicine 3, University Hospital of Pisa, Pisa, Italy., Chiriacò G; Department of Physics and Astronomy 'Ettore Majorana', University of Catania, Catania, Italy., Leonetti S; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Interdisciplinary Research Center 'Health Science', Sant'Anna School of Advanced Studies, Pisa, Italy., Natali A; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Cardiopulmonary Lab, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Solini A; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Tricò D; Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.

Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Autor: MOCCIA, M., SANTONI, L., VACCARI, I., AFFINITO, G., CALIENDO, D., RUBBA, F., LANZILLO, R., TRIASSI, M., MORRA, V. BRESCIA, PALLADINO, R.

Publikováno v: European Review for Medical & Pharmacological Sciences; Jan2024, Vol. 28 Issue 1, p411-418, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.

Autor: Filippi M; Neurology Unit, Neurorehabilitation Unit, Neurophysiology Service, and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy. filippi.massimo@hsr.it.; Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it., Grimaldi L; Multiple Sclerosis Center, Institute Foundation G. Giglio, Cefalù, PA, Italy., Conte A; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.; Multiple Sclerosis Center, Policlinico Umberto I Hospital, Rome, Italy.; IRCCS Neuromed, Pozzilli, IS, Italy., Totaro R; Demyelinating Disease Center, Department of Neurology, San Salvatore Hospital, L'Aquila, Italy., Valente MR; Clinical Neurology, Santa Maria della Misericordia University Hospital, and Department of Medicine, University of Udine, Udine, Italy., Malucchi S; SCDO Neurologia, S. Luigi Gonzaga University Hospital, Orbassano, TO, Italy., Granella F; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy., Cordioli C; Multiple Sclerosis Center, ASST Spedali Civili di Brescia, Montichiari Hospital (Brescia), Brescia, Italy., Brescia Morra V; Multiple Sclerosis Clinical Care and Research Center, Department of Neuroscience (NSRO), Federico II University Hospital, Naples, Italy., Zanetta C; Neurology Unit, Neurorehabilitation Unit, Neurophysiology Service, and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy., Perini D; Biogen Italia, Milan, Italy., Santoni L; Biogen Italia, Milan, Italy.

Publikováno v: Journal of neurology [J Neurol] 2024 Jan; Vol. 271 (1), pp. 340-354. Date of Electronic Publication: 2023 Sep 16.